Bronchiolitis Obliterans Syndrome (BOS) Completed Phase 4 Trials for Erythromycin (DB00199)

Also known as: Obliterative Bronchiolitis / Bronchiolitis Obliterans / Bronchiolitis Obliterans (BO) / Bronchiolitis Obliterans Syndrome / Obliterative bronchiolitis (disorder)

IndicationStatusPhase
DBCOND0071683 (Bronchiolitis Obliterans Syndrome (BOS))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00367419Use of Erythromycin in Mustard-Induced BronchiolitisTreatment